CSI tatrc r & d proposal #10027002

Ended Definitive Contract Awarded Last action

Contract number
W81XWH10C0287
Awardee
Awarding agency
Obligated
$4,559,598

Award facts

Contract value 100% obligated
  • $4,559,597.64 Current, with exercised options
  • $4,559,599.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Basic Research
Pricing
Cost Plus Fixed Fee
Place of performance
Aiea, HI 96701, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00003 · DE-obligation -$1
Other Administrative Action P00002 $0
Other Administrative Action P00001 $2,000,000
Original award $2,559,599

About this award

The Department of Defense Medical Command awarded a definitive contract to Panthera Biopharma, LLC for CSI TATRC research and development on September 30, 2010, with a ceiling value of $4,559,599.

The contract was structured on a cost-plus-fixed-fee basis with no set-aside. Place of performance is Aiea, HI. The contract ultimate completion date was October 29, 2012.

Quick answers

Who was awarded contract W81XWH10C0287?

W81XWH10C0287 was awarded to Panthera Biopharma, LLC by Medical Command (Department of the Army) on September 30, 2010.

How much is contract W81XWH10C0287 worth?

The government has obligated $4,559,598 on W81XWH10C0287. Its potential value, with all options, is $4,559,599.

Was contract W81XWH10C0287 competed?

The extent of competition for W81XWH10C0287 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award